Bevacizumab: serious neurological disorders and nasal perforations.
The list of bevacizumab's adverse effects continues to grow: the latest additions are reversible posterior leukoencephalopathy and perforation of the nasal septum.
D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D009300:Nasal Septum / Q000187:drug effects*; D009422:Nervous System Diseases / Q000139:chemically induced*; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal